These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 18834856)
1. TRAIL induces MMP-9 expression via ERK activation in human astrocytoma cells. Kim JH; Choi C; Benveniste EN; Kwon D Biochem Biophys Res Commun; 2008 Dec; 377(1):195-9. PubMed ID: 18834856 [TBL] [Abstract][Full Text] [Related]
2. IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells. Lee EJ; Park SS; Kim WJ; Moon SK Oncol Rep; 2012 Sep; 28(3):1084-90. PubMed ID: 22710862 [TBL] [Abstract][Full Text] [Related]
4. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016 [TBL] [Abstract][Full Text] [Related]
5. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation. Smola-Hess S; Schnitzler R; Hadaschik D; Smola H; Mauch C; Krieg T; Pfister H Exp Cell Res; 2001 Jul; 267(2):205-15. PubMed ID: 11426939 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568 [TBL] [Abstract][Full Text] [Related]
7. The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell. Zhou DH; Trauzold A; Röder C; Pan G; Zheng C; Kalthoff H Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):201-9. PubMed ID: 18397859 [TBL] [Abstract][Full Text] [Related]
8. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells. Abidi P; Zhang F; Li C; Liu J Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244 [TBL] [Abstract][Full Text] [Related]
9. Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL. Romagnoli M; Desplanques G; Maïga S; Legouill S; Dreano M; Bataille R; Barillé-Nion S Clin Cancer Res; 2007 Oct; 13(20):6010-8. PubMed ID: 17947462 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Xu J; Zhou JY; Wu GS Cancer Res; 2006 Oct; 66(20):10092-9. PubMed ID: 17047073 [TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B. Tang W; Wang W; Zhang Y; Liu S; Liu Y; Zheng D FEBS J; 2009 Jan; 276(2):581-93. PubMed ID: 19120450 [TBL] [Abstract][Full Text] [Related]
12. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions. Meurette O; Rebillard A; Huc L; Le Moigne G; Merino D; Micheau O; Lagadic-Gossmann D; Dimanche-Boitrel MT Cancer Res; 2007 Jan; 67(1):218-26. PubMed ID: 17210702 [TBL] [Abstract][Full Text] [Related]
13. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Mendoza FJ; Ishdorj G; Hu X; Gibson SB Apoptosis; 2008 Jun; 13(6):756-70. PubMed ID: 18421578 [TBL] [Abstract][Full Text] [Related]
14. The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases. Audo R; Combe B; Coulet B; Morel J; Hahne M Cell Death Differ; 2009 Sep; 16(9):1227-37. PubMed ID: 19407827 [TBL] [Abstract][Full Text] [Related]
15. Caspase-dependent generation of reactive oxygen species in human astrocytoma cells contributes to resistance to TRAIL-mediated apoptosis. Choi K; Ryu SW; Song S; Choi H; Kang SW; Choi C Cell Death Differ; 2010 May; 17(5):833-45. PubMed ID: 19876066 [TBL] [Abstract][Full Text] [Related]
16. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684 [TBL] [Abstract][Full Text] [Related]
17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Secchiero P; Melloni E; Corallini F; Beltrami AP; Alviano F; Milani D; D'Aurizio F; di Iasio MG; Cesselli D; Bagnara GP; Zauli G Stem Cells; 2008 Nov; 26(11):2955-63. PubMed ID: 18772312 [TBL] [Abstract][Full Text] [Related]
19. TRAIL signalling: decisions between life and death. Falschlehner C; Emmerich CH; Gerlach B; Walczak H Int J Biochem Cell Biol; 2007; 39(7-8):1462-75. PubMed ID: 17403612 [TBL] [Abstract][Full Text] [Related]
20. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Taniguchi H; Yoshida T; Horinaka M; Yasuda T; Goda AE; Konishi M; Wakada M; Kataoka K; Yoshikawa T; Sakai T Cancer Res; 2008 Nov; 68(21):8918-27. PubMed ID: 18974136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]